犬向け関節炎治療の市場規模・シェア・成長分析 (関節炎の種類別、投与経路別、治療法別、エンドユーザー別、地域別)：産業予測 (2025～2032年)

世界の犬向け関節炎治療の市場規模は、2023年に27億米ドルと評価され、2024年の28億3,000万米ドルから2032年には41億2,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは4.8％で成長する見通しです。

世界の犬向け関節炎治療市場は、特に高齢化、肥満、犬種が変わりやすい犬における変形性関節症の有病率の上昇に牽引され、力強い成長を目の当たりにしています。特に先進地域では、定期的な検査と早期診断の動向が顕著であり、ペットの飼い主は移動と疼痛管理のために獣医療を優先するようになっています。この成長は、モノクローナル抗体、非ステロイド性抗炎症薬（NSAID）、再生医療を含む長期治療薬に対する需要の高まりによってさらに促進されます。遠隔医療サービスやオンライン動物薬局の拡大も、市場浸透を高めています。動物用医薬品企業による研究開発への一貫した投資は、市場の見通しを明るいものにしています。全体として、ペット向け医療や予防治療への支出の増加が、犬向け関節炎治療分野の好成長を後押ししています。

目次

イントロダクション

• 分析目的
• 市場範囲
• 定義

分析手法

• 情報調達
• 二次・一次データの手法
• 市場規模予測
• 市場の想定と制約

エグゼクティブサマリー

• 市場の概要と展望
• 需給動向の分析
• セグメント別の機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

市場の主な考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場魅力度指数 (2024年)
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術進歩
• ケーススタディ

世界の犬向け関節炎治療の市場規模・CAGR：関節炎の種類別 (2025～2032年)

• 市場概要
• 変形性関節症
• 骨軟骨症
• 関節リウマチ
• 外傷性関節炎

世界の犬向け関節炎治療の市場規模・CAGR：投与経路別 (2025～2032年)

• 市場概要
• 経口
• 非経口
• その他

世界の犬向け関節炎治療の市場規模・CAGR：治療法別 (2025～2032年)

• 市場概要
• 非ステロイド性抗炎症薬（NSAID）
• オピオイド
• 幹細胞療法
• 同種幹細胞
• 自己幹細胞

世界の犬向け関節炎治療の市場規模・CAGR：エンドユーザー別 (2025～2032年)

• 市場概要
• 病院
• 専門クリニック
• その他

世界の犬向け関節炎治療の市場規模・CAGR：流通チャネル別 (2025～2032年)

• 市場概要
• 動物病院・クリニック
• 小売薬局
• オンライン薬局
• その他

世界の犬向け関節炎治療の市場規模・CAGR (2025～2032年)

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング (2024年)
• 主要企業が採用した戦略
• 市場の近年の動向
• 主要企業の市場シェア (2024年)
• 主要企業のプロファイル
  • 企業概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較 (2022～2024年)

主要企業のプロファイル

• Boehringer Ingelheim
• Zoetis
• Elanco
• Decora Pharmaceuticals
• Merck Animal Health
• American Regent, Inc.
• Bayer AG
• Nutramax Laboratories Veterinary Sciences, Inc.
• VetStem, Inc.
• Virbac

結論と提言

Global Canine Arthritis Treatment Market size was valued at USD 2.7 billion in 2023 and is poised to grow from USD 2.83 billion in 2024 to USD 4.12 billion by 2032, growing at a CAGR of 4.8% during the forecast period (2025-2032).

The global canine arthritis treatment market is witnessing robust growth driven by the rising prevalence of osteoarthritis, particularly in aging, obese, and breed-prone dogs. Pet owners increasingly prioritize veterinary care for mobility and pain management, with a marked trend towards regular examinations and early diagnoses, especially in developed regions. This growth is further fueled by escalating demand for long-term therapeutics, including monoclonal antibodies, NSAIDs, and regenerative medicines. The expansion of telehealth services and online veterinary pharmacies is also enhancing market penetration. Consistent investments in research and development by veterinary pharmaceutical companies underline a positive market outlook. Overall, the increase in spending on pet healthcare and preventative treatments is propelling favorable growth in the canine arthritis treatment sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Canine Arthritis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Canine Arthritis Treatment Market Segments Analysis

Global Canine Arthritis Treatment Market is segmented by Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel and region. Based on Arthritis Type, the market is segmented into Osteoarthritis, Osteochondrosis, Rheumatoid arthritis and Traumatic arthritis. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on Treatment, the market is segmented into Non-steroidal anti-inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Allogeneic Stem Cells and Autologous Stem Cells. Based on End-Users, the market is segmented into Hospitals, Speciality Clinics and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market is primarily driven by significant advancements in nutrition and veterinary medicine, which have enabled dogs to age more gracefully. As a result, there has been an increase in age-related diseases like arthritis, creating a heightened demand for wellness support and chronic care services specifically tailored for these conditions. This demographic shift highlights the growing focus on aging dogs, prompting substantial investments in treatments and medications aimed at promoting long-term joint health. Consequently, the market is evolving to meet the needs of pet owners seeking effective solutions for their canine companions suffering from arthritis.

Restraints in the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market faces significant restraints due to the high costs associated with biologics and regenerative therapies, which restrict options for pet owners in low- and middle-income communities. This challenge is further exacerbated in rural areas, where there is often a shortage of veterinary specialists, making it difficult for pet owners to obtain timely diagnoses and management of these advanced therapies. These accessibility issues not only hinder the adoption of regenerative treatments but also impede the development of pet healthcare systems in emerging markets, ultimately affecting the overall growth potential of the market.

Market Trends of the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market is witnessing a significant trend towards biologic and regenerative therapies, particularly monoclonal antibodies and stem cell treatments, which are leading the charge in innovative approaches. These therapies prioritize personalized care and sustainability, offering prolonged pain relief with minimal side effects, which resonates with both pet owners and veterinary professionals. This shift represents a strategic evolution in the market, emphasizing enhanced chronic care and the rapid advancement of veterinarian therapeutic solutions. As demand for more effective and less invasive treatments escalates, the market is evolving to meet these preferences, driving growth and innovation in canine arthritis management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies

Global Canine Arthritis Treatment Market Size by Arthritis Type & CAGR (2025-2032)

• Market Overview
• Osteoarthritis
• Osteochondrosis
• Rheumatoid arthritis
• Traumatic arthritis

Global Canine Arthritis Treatment Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Parenteral
• Others

Global Canine Arthritis Treatment Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Non-steroidal anti-inflammatory Medications (NSAIDs)
• Opioids
• Stem Cell Therapy
• Allogeneic Stem Cells
• Autologous Stem Cells

Global Canine Arthritis Treatment Market Size by End-Users & CAGR (2025-2032)

• Market Overview
• Hospitals
• Speciality Clinics
• Others

Global Canine Arthritis Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies
• Others

Global Canine Arthritis Treatment Market Size & CAGR (2025-2032)

• North America (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • US
  • Canada
• Europe (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Decora Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Regent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutramax Laboratories Veterinary Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetStem, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations